MI and PV (Medical Information & Pharmacovigilance)
Medical Information (MI) and Pharmacovigilance (PV) are closely connected. MI is often where questions, concerns, and potential safety information appear first. PV is where safety data is assessed, processed, and reported. When these functions are joined up, you reduce handover risk, improve traceability, and respond faster to both stakeholders and regulators. MI–PV integration is a practical way to stay compliant while scaling efficiently.
At Arriello, we help life sciences teams run MI services in a way that supports PV workflows, so potential adverse events and product complaints are captured consistently and routed through agreed pathways.
Why MI and PV are better together
When MI and PV operate in silos, critical details can be missed, duplicated, or delayed. A connected MI–PV model helps you:
- Capture potential safety signals earlier (MI is often the first point of contact).
- Improve inspection readiness with clearer audit trails and consistent case histories.
- Scale more predictably as enquiry volumes and geographies expand.
- Reduce handover friction by aligning intake, triage, follow-up, and reconciliation.
Medical Information services we provide
MI enquiry handling (multi-channel)
We manage and respond to enquiries from healthcare professionals, patients, and other stakeholders using approved content and defined response pathways.
Channels can include phone, email, webforms, voicemail, and written correspondence (depending on your model).
Adverse event (AE) and product complaint intake
Our MI intake teams are trained to identify and capture potential adverse events and product quality complaints during enquiries, then route them promptly to the appropriate safety and quality workflows.
Follow-up support
Where your SOPs require it, we can support outbound follow-up to obtain missing information after initial intake, aligned to agreed escalation pathways.
MI content and knowledge base support
We can support development and maintenance of MI content such as standard responses and FAQs to help ensure consistency and efficiency.
Digital and social media monitoring
Monitoring can be included to identify potential enquiries or safety-relevant information from digital channels, depending on scope and governance.
Crisis / high-volume surge support
For spikes in enquiries (for example, safety communications or recalls), a scalable model can be put in place with pre-defined scripts and routing.
How MI supports PV outcomes (and vice versa)
Arriello’s PV services include end-to-end safety operations (case processing, expedited reporting, aggregate reports, literature monitoring, signal management, and more).
MI strengthens those outcomes by improving the quality and completeness of what comes in.
Where clients see value:
- Faster identification of safety-relevant information from enquiries.
- Reduced duplication and cleaner case histories through MI–PV reconciliation.
- Better readiness as organizations scale into new markets.
What you can outsource, and what stays with you
Typically handled by Arriello :
- Enquiry intake and documentation
- Tier 1 responses (approved materials)
- Safety and product complaint capture and routing
- Follow-up support (if agreed)
- MI–PV reconciliation reports
Typically retained by clients (example):
- Final medical sign-off on non-standard scientific responses
- Final approval of MI content library updates
- Safety governance decisions (unless PV is also outsourced to Arriello)
FAQ
Q1: What is Medical Information (MI)?
Medical Information supports accurate, balanced responses to questions about a medicinal product from healthcare professionals, patients, and other stakeholders, using approved sources and governed processes.
MI can be the first place a potential adverse event is mentioned. A connected MI–PV workflow ensures safety-relevant information is captured, routed, and traceable for PV processing and reporting.
Q3: Can MI teams capture adverse events and product complaints?
Yes, when trained and governed appropriately. MI intake can identify potential adverse events and product quality complaints during enquiries and route them into PV and quality workflows.
Q4: What channels can MI cover?
Models can include phone, email, web enquiries, voicemail, and written correspondence, depending on agreed scope and governance.
Q5: Do you support MI follow-up?
Where agreed, MI teams can support follow-up to obtain missing information and complete records according to SOPs and escalation pathways.
Q6: How do you prevent MI and PV records from drifting apart?
Through defined handover rules and reconciliation as defined by the program between MI and PV datasets and teams.
Q7: Can Arriello support PV as well as MI?
Yes. Arriello provides PV services across clinical safety and post-marketing PV operations, including case processing and reporting, literature monitoring, and signal management.
Q8: Why do some companies outsource MI and PV together?
A combined model can improve consistency, inspection readiness, scalability, and predictable resourcing as pipelines and geographies expand.
Click an area to see the countries where we operate…
Albania
Austria
Belarus
Belgium
Bosnia and Herzegovina
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany
Greece
Hungary
Iceland
Ireland
Italy
Kosovo
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Moldova
Montenegro
Netherlands
Northern Macedonia
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Ukraine
United Kingdom
Armenia
Azerbajan
Bahrain
Bangladesh
Brunei Darussalam
China
Hong Kong
India
Indonesia
Iran
Iraq
Israel
Japan
Jordan
Kazakhstan
Kuwait
Kyrgyzstan
Lebanon
Macao
Malaysia
Mongolia
North Korea
Oman
Pakistan
Palestine
Philippines
Qatar
Saudi Arabia
Singapore
South Korea
Syrian Arab Republic
Taiwan
Tajikistan
Thailand
Turkey
Turkmenistan
UAE
Uzbekistan
Vietnam
Yemen
Australia
New Zealand
Argentina
Aruba
Bolivia
Brazil
Chile
Colombia
Costa Rica
Curaçao
Dominican Republic
Ecuador
El Salvador
Falkland Islands
French Guiana
Guatemala
Guyana
Honduras
Nicaragua
Panama
Paraguay
Peru
Puerto Rico
Suriname
Trinidad & Tobago
Uruguay
Venezuela
Bahamas
Barbados
Belize
Canada
Jamaica
Mexico
USA
Algeria
Botswana
Burkina Faso
Cameroon
Congo
Egypt
Ethiopia
Gabon
Ghana
Guinea
Kenya
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Nigeria
Rwanda
Senegal
South Africa
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zimbabwe
What our clients say about us.
Arriello has highly knowledgeable staff in all countries with a very professional attitude. They are very fast in responding when needed.
My experience with Arriello was an overwhelmingly positive one. Very professional, accommodating and readily able to adapt to our needs even as they changed.
After evaluating several vendors to help us set up and manage our global literature screening process, we chose Arriello due to their professionalism and thorough understanding of global requirements.
I’d like to personally thank you for the high quality of Regulatory support you’ve given us so far, especially Gabi and Maria and your local partners. We’re very satisfied with the service.
